Is Akso Health Group (AHG) a Buy, Sell, or Hold?
NASDAQ : AHG
Akso Health Group — News
$1.6 USD
$0.02 (1.27%)
- Volume
- 16.81K
- Average Volume
- 59.74K
- Market Capitalization
- $151.57M
- P/E Ratio
- -7.87
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $2.50
- Year Low
- $1.10
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.53
| Source | Headline |
|---|---|
|
AHG Announces Initiation of World-Class, Proprietary Brain-Computer Interface R&D Program - Targeting the Next Frontier of Human Neurotechnology
QINGDAO, China, April 27, 2026 /PRNewswire/ -- Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the commencement of its next-generation, proprietary Brain-Computer Interface (BCI) technology research and development program. The Company is establishing the foundational R&D infrastructure necessary to develop and commercialize BCI technology, which it believes represents one of the most transformative and high-value technology frontiers of the 21st century. prnewswire.com - 2026-04-27 09:00:00 |
